T1	Age 65 68	Age
E1	Age:T1
T2	Eq-Comparison 70 73	20-
E2	Eq-Comparison:T2 Value:T46 Operator:T47
T3	Condition 100 116	Fitzpatrick skin
E3	Condition:T3 Name:T49
T4	Eq-Comparison 117 129	types III-IV
E4	Eq-Comparison:T4 Value:T50 Operator:T51 Value:T52
T5	Condition 177 206	platelet dysfunction syndrome
E5	Condition:T5 Name:T53
T6	Condition 208 233	critical thrombocytopenia
E6	Condition:T6 Name:T55
T7	Eq-Comparison 235 245	<50,000/ul
E7	Eq-Comparison:T7 Operator:T56 Value:T57
T8	Condition 252 275	hemodynamic instability
E8	Condition:T8 Name:T58
T9	Modifier 301 308	chronic
E9	Modifier:T9
T10	Condition 309 324	medical illness
E10	Condition:T10 Name:T59
T11	Condition 331 339	diabetes
E11	Condition:T11 Name:T60
T12	Modifier 341 348	chronic
E12	Modifier:T12
T13	Condition 349 359	infections
E13	Condition:T13 Name:T61
T14	Or 361 364	and
E14	Or:T14
T15	Modifier 365 370	blood
E15	Modifier:T15
T16	Condition 371 381	dyscrasias
E16	Condition:T16
T17	Condition 408 441	local inflammatory skin disorders
E17	Condition:T17 Name:T63
T18	Or 442 444	or
E18	Or:T18
T19	Eq-Comparison 445 451	active
E19	Eq-Comparison:T19 Temporal-Period:T64
T20	Condition 452 468	herpes infection
E20	Condition:T20 Name:T65
T21	Modifier 476 480	site
E21	Modifier:T21
T22	Procedure 488 497	procedure
E22	Procedure:T22
T23	Eq-Comparison 518 520	on
E23	Eq-Comparison:T23 Temporal-Period:T66
T24	Drug 539 554	anti-coagulants
E24	Drug:T24 Name:T67
T25	Or 555 557	or
E25	Or:T25
T26	Drug 558 595	non-steroidal anti-inflammatory drugs
E26	Drug:T26 Name:T68
T27	Drug 597 602	NSAID
E27	Drug:T27 Name:T69
T28	Eq-Comparison 604 619	within 48 hours
E28	Eq-Comparison:T28 Operator:T70 Value:T71 Temporal-Unit:T72
T29	Temporal-Connection 620 622	of
E29	Temporal-Connection:T29
A1	Temporal-Connection-Type-Value E29 before
T30	Procedure 623 632	procedure
E30	Procedure:T30 Name:T73
T31	Observation 644 661	Haemoglobin level
E31	Observation:T31 Name:T74
T32	Eq-Comparison 661 670	< 10 g/dl
E32	Eq-Comparison:T32 Operator:T75 Value:T76 Unit:T77 Unit:T78
T33	Negation 681 689	excluded
E33	Negation:T33
T34	Condition 715 747	cancer- especially hematopoietic
E34	Condition:T34 Name:T79
T35	Or 748 750	or
E35	Or:T35
T36	Modifier 754 758	bone
E36	Modifier:T36
T37	Condition 770 778	Pregnant
E37	Condition:T37 Name:T80
T38	Drug 812 827	corticosteroids
E38	Drug:T38
T39	Procedure 828 837	injection
E39	Procedure:T39
T40	Procedure 841 850	treatment
E40	Procedure:T40
T41	Eq-Comparison 856 870	within 1 month
E41	Eq-Comparison:T41 Operator:T83 Value:T84 Temporal-Unit:T85
T42	Or 871 873	or
E42	Or:T42
T43	Modifier 874 882	systemic
E43	Modifier:T43
T44	Drug 890 905	corticosteroids
E44	Drug:T44 Name:T86
T45	Eq-Comparison 906 920	within 2 weeks
E45	Eq-Comparison:T45 Operator:T87 Value:T88 Temporal-Unit:T89
T46	Eq-Value 70 72	20
T47	Eq-Operator 72 73	-
A2	Eq-Operator-Value T47 BETWEEN
T48	Eq-Value 73 75	50
T49	Condition-Name 100 116	Fitzpatrick skin
T50	Eq-Value 123 126	III
T51	Eq-Operator 126 127	-
A3	Eq-Operator-Value T51 BETWEEN
T52	Eq-Value 127 129	IV
T53	Condition-Name 177 206	platelet dysfunction syndrome
T54	Severity 208 216	critical
A4	Severity-Value T54 severe
T55	Condition-Name 217 233	thrombocytopenia
T56	Eq-Operator 235 236	<
A5	Eq-Operator-Value T56 LT
T57	Eq-Value 236 245	50,000/ul
T58	Condition-Name 252 275	hemodynamic instability
T59	Condition-Name 309 324	medical illness
T60	Condition-Name 331 339	diabetes
T61	Condition-Name 349 359	infections
T62	Condition-Name 365 381	blood dyscrasias
T63	Condition-Name 408 441	local inflammatory skin disorders
T64	Eq-Temporal-Period 445 451	active
A6	Eq-Temporal-Period-Value T64 present
T65	Condition-Name 452 468	herpes infection
T66	Eq-Temporal-Period 518 520	on
A7	Eq-Temporal-Period-Value T66 present
T67	Drug-Name 539 554	anti-coagulants
T68	Drug-Name 558 595	non-steroidal anti-inflammatory drugs
T69	Drug-Name 597 602	NSAID
T70	Eq-Operator 604 610	within
A8	Eq-Operator-Value T70 LTEQ
T71	Eq-Value 611 613	48
T72	Eq-Temporal-Unit 614 619	hours
A9	Eq-Temporal-Unit-Value T72 hour
T73	Procedure-Name 623 632	procedure
T74	Observation-Name 644 661	Haemoglobin level
A10	Observation-Type-Value T74 lab
T75	Eq-Operator 661 662	<
A11	Eq-Operator-Value T75 LT
T76	Eq-Value 663 665	10
T77	Eq-Unit 666 667	g
T78	Eq-Unit 668 670	dl
T79	Condition-Name 715 747	cancer- especially hematopoietic
T80	Condition-Name 770 778	Pregnant
T81	Life-Stage-And-Gender 779 786	females
A12	Life-Stage-And-Gender-Type T81 female
T82	Drug-Name 812 837	corticosteroids injection
T83	Eq-Operator 856 862	within
A13	Eq-Operator-Value T83 LTEQ
T84	Eq-Value 863 864	1
T85	Eq-Temporal-Unit 865 870	month
A14	Eq-Temporal-Unit-Value T85 month
T86	Drug-Name 890 905	corticosteroids
T87	Eq-Operator 906 912	within
A15	Eq-Operator-Value T87 LTEQ
T88	Eq-Value 913 914	2
T89	Eq-Temporal-Unit 915 920	weeks
A16	Eq-Temporal-Unit-Value T89 week